<p>Kory James Wentworth, Chief Financial Officer of Entrada Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Entrada Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001725663-25-000004), on November 24, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

TRDA

<p>Kory James Wentworth, CFO of Entrada Therapeutics Inc., reported the disposal of common shares of the company. The original filing is available via EDGAR, the SEC's system. This information is provided by Public Technologies using AI and is for informational purposes only.</p>

Entrada Therapeutics CFO Kory James Wentworth Reports Disposal of Common Shares